Differential inhibition of APOBEC3 DNA-mutator isozymes by fluoro- versus non-fluoro-substituted 2'-deoxyzebularine embedded in single-stranded DNA.
The APOBEC3 (APOBEC3A-H) enzyme family is part of the human innate immune system that restricts pathogens by scrambling pathogenic single-stranded DNA (ssDNA) via deamination of cytosines to uracils. However, APOBEC3-mediated mutagenesis of viral and cancer DNA promotes its evolution, enabling disease progression and development of drug resistance. Therefore, APOBEC3 inhibition offers a new strategy to complement existing anti-viral and anti-cancer therapies by making such therapies effective for longer periods of time, thereby preventing the emergence of drug resistance. Here, we have synthesised 2'-deoxynucleoside forms of several known inhibitors of cytidine deaminase (CDA), incorporated them into oligodeoxynucleotides (oligos) in place of 2'-deoxycytidine in the preferred substrates of APOBEC3A, APOBEC3B, and APOBEC3G, and evaluated their inhibitory potential against these enzymes. An oligo with 5-fluoro-2'-deoxyzebularine (5FdZ) exhibited a 3.5 times better inhibition constant in comparison with the comparable 2'-deoxyzebularine (dZ) containing oligo against APOBEC3B. A similar trend of inhibition was observed for wild-type APOBEC3A. In contrast, use of 5FdZ in an oligo designed for APOBEC3G inhibition resulted in a less potent inhibitor than the dZ-containing oligo for both APOBEC3GCTD and full-length wild-type APOBEC3G.